Bile Acids Blood Test: Itching and Urgent Care

Categories
Articles
Liver Health Lab Interpretation 2026 Update Pregnancy Safety

Persistent itch can be a skin problem, a medication effect, or an early signal of impaired bile flow. During pregnancy, the same symptom deserves same-day maternity advice—even when the first result is normal.

📖 ~11 minutes 📅
📝 Published: 🩺 Medically Reviewed: ✅ Evidence-Based
⚡ Quick Summary v1.0 —
  1. Bile acids test measures bile compounds in serum; a result of 19 micromol/L or higher in pregnancy supports intrahepatic cholestasis after other causes are considered.
  2. Severe pregnancy cholestasis means peak bile acids of 100 micromol/L or higher and requires urgent obstetric-led planning because fetal risk rises most clearly in this range.
  3. Normal first result does not exclude early intrahepatic cholestasis of pregnancy; itch can precede an abnormal result by days or occasionally weeks.
  4. Non-fasting samples are acceptable for suspected pregnancy cholestasis in current UK guidance, but the laboratory method and its own reference interval still matter.
  5. Cholestatic liver pattern usually means alkaline phosphatase and GGT rise out of proportion to ALT and AST; bilirubin may remain normal early on.
  6. Same-day care is appropriate for itching in pregnancy with reduced fetal movements, jaundice, dark urine, pale stools, fever, right-upper abdominal pain, or feeling acutely unwell.
  7. Repeat testing is a clinical decision, not a failure of the first test; symptom change and gestational age help determine whether repeat blood work is needed within about 1 week.
  8. Do not self-treat with supplements marketed for liver cleansing during unexplained itch; some herbal products can cause or worsen cholestatic liver injury.

When an itchy person needs a bile acids test urgently

A bile acids blood test is most urgent when itching occurs in pregnancy, especially on the palms or soles, worsens at night, or appears without a convincing rash. Call your maternity unit or obstetric team the same day; reduced fetal movement, jaundice, dark urine, pale stool, fever, or right-upper abdominal pain warrants urgent assessment rather than waiting for an outpatient test.

Bile acids blood test shown beside an anatomical liver and bile duct cross-section
Figure 1: Anatomical liver and bile ducts explain why retained bile compounds can cause itch.

Outside pregnancy, generalized itch lasting more than 6 weeks without an obvious skin explanation merits a medication review and targeted laboratory work-up. In my practice, the clue is often itch that is much worse after a hot shower or at bedtime but has no primary rash—scratch marks are a consequence, not a diagnosis; our itchy-skin blood test guide explains the wider screen.

A bile acids result is not a stand-alone emergency number for non-pregnant adults. The urgency comes from the pattern: new jaundice, a total bilirubin above 3 mg/dL (51 micromol/L), fever with abdominal pain, or confusion can indicate obstruction, infection, or impaired liver function and needs prompt in-person evaluation.

Dr. Thomas Klein, MD, advises patients not to assume itch is “just dry skin” when it starts abruptly alongside urine or stool colour changes. Kantesti is an AI blood test analyzer that places a reported bile-acid result next to bilirubin, ALT, AST, ALP, GGT, albumin, and the date of symptoms; it does not replace urgent maternity or emergency care.

What a bile acids blood test actually measures

A bile acids blood test measures the concentration of bile acids circulating in serum rather than the amount of bile stored in the gallbladder. High circulating values suggest that the liver is not transporting bile acids into bile normally, although the test alone cannot identify the cause.

Three-dimensional liver cells transporting bile acids toward tiny bile canaliculi
Figure 2: Hepatocytes normally move bile acids into microscopic bile canaliculi for excretion.

Bile acids are made from cholesterol in hepatocytes, modified by intestinal bacteria, then recycled through the portal circulation several times daily. This recycling explains why a meal can change the value and why a single result should be read with the laboratory’s assay, sampling context, and symptoms—not against a universal internet range.

Most clinical laboratories measure total serum bile acids, often by an enzymatic cycling method; they do not routinely separate cholic, chenodeoxycholic, and conjugated fractions. A result may be reported in micromol/L, and 1 micromol/L is not interchangeable with a bilirubin value in mg/dL.

For people reviewing a multi-test report, what a liver panel includes is a useful companion because bile acids are often ordered separately from routine liver chemistry. That separation is a practical reason an ordinary “normal LFT” cannot reliably rule out early pregnancy cholestasis.

Pregnancy bile acid thresholds and what high results mean

In pregnancy, a non-fasting total bile acid concentration of 19 micromol/L or above is commonly used in UK practice to support a diagnosis of intrahepatic cholestasis of pregnancy when itching is present and competing causes have been assessed. Peak values of 40-99 micromol/L indicate moderate disease, while 100 micromol/L or above indicates severe disease with the clearest evidence of increased stillbirth risk.

Laboratory serum analysis for bile acids blood test during pregnancy-related cholestasis assessment
Figure 3: Serum bile-acid measurement guides severity assessment in suspected pregnancy cholestasis.

The thresholds are risk bands, not a score for how miserable someone feels. RCOG’s 2022 Green-top Guideline describes mild ICP as 19-39 micromol/L, moderate ICP as 40-99 micromol/L, and severe ICP as 100 micromol/L or more; each maternity service adapts surveillance and birth planning to the whole obstetric picture.

The individual participant data meta-analysis by Ovadia et al. found a stillbirth prevalence of 3.44% among singleton pregnancies with peak bile acids of at least 100 micromol/L, compared with 0.13% below 40 micromol/L (Ovadia et al., 2019). That finding is why clinicians focus on the highest documented value, not merely the result from the day itching feels worst.

Some North American services have historically used more than 10 micromol/L as an abnormal threshold, while UK guidance uses 19 micromol/L for non-fasting testing. This is one of those areas where context matters more than pretending every laboratory uses the same cut-off; compare the result with its printed interval and maternity protocol.

Below diagnostic threshold <19 micromol/L Does not confirm ICP; repeat if typical itch persists.
Mild ICP range 19-39 micromol/L Maternity assessment and individualized repeat testing.
Moderate ICP range 40-99 micromol/L Higher-risk category requiring obstetric-led follow-up.
Severe ICP range >=100 micromol/L Urgent obstetric planning and close fetal-risk discussion.

Which itching pattern raises concern for cholestasis?

Itching from cholestasis is often generalized, can be intense on the palms and soles, and commonly becomes more troublesome at night; it usually starts without a primary rash. These features raise suspicion but do not prove a liver cause, because eczema, scabies, pregnancy dermatoses, thyroid disease, kidney disease, and medicines can also itch.

Watercolor anatomy of liver, gallbladder and bile ducts related to unexplained itching
Figure 4: The bile drainage system is a relevant hidden cause of itch without rash.

In a typical maternity clinic scenario, a person at 32 weeks reports two sleepless nights from itching feet but has no rash and normal blood pressure. I would not dismiss this because fetal monitoring is reassuring that morning: the relevant next step is bile acids plus liver chemistry, followed by a defined plan if symptoms continue.

A visible rash changes the differential but does not automatically exclude ICP; people can have eczema or scratch-related skin changes and cholestasis at the same time. Take photographs before applying multiple new creams, and tell the clinician about new antibiotics, antifungals, hormones, anticonvulsants, and over-the-counter products.

Unexplained itch with yellow eyes or skin needs assessment for bilirubin patterns rather than cosmetic treatment alone. Our explanation of when bilirubin becomes concerning helps distinguish a mild isolated result from symptoms that warrant faster care.

Why a normal first bile acids result may need repeating

A normal bile acids result does not reliably rule out early intrahepatic cholestasis of pregnancy because itch can begin before biochemical elevation. If characteristic itching persists, clinicians commonly repeat bile acids and liver tests in about 1 week, sooner if symptoms escalate or new warning signs appear.

Clinical diagnostic pathway for repeat bile acid and liver chemistry sample processing
Figure 5: Repeat sampling captures biochemical change that may follow the onset of itching.

The practical mistake I see is treating a first normal result as a lifetime clearance certificate. Bile acids can vary over days, and pregnancy physiology changes rapidly in the third trimester; record when itch began, where it occurs, sleep disruption, and whether a rash was present at the time of each draw.

RCOG advises repeating liver blood tests after 1 week following diagnosis and tailoring further tests to the clinical situation. For suspected but unconfirmed disease, the same principle applies: the obstetric clinician should set the interval rather than relying on symptoms alone or on a home fetal monitor.

Blood-test differences between visits are not always biological change—assay variation, fasting status, and sample timing contribute. Kantesti AI is an AI blood test interpretation platform that can display sequential results with their dates, which makes a rising pattern easier to discuss with the clinician who knows the pregnancy.

Does fasting change a bile acids blood test result?

Fasting can lower serum bile acid concentrations after a meal, but suspected pregnancy cholestasis should not be delayed solely to obtain a fasting specimen. UK guidance supports non-fasting bile-acid testing because it better fits real-world maternity assessment and avoids missed or delayed testing.

Precision analyzer processing a serum bile acid assay with frosted glass laboratory reflections
Figure 6: Automated enzymatic assays quantify total bile acids from a prepared serum sample.

Ask the laboratory or maternity team whether the result is fasting or non-fasting and which reference interval applies. A meal containing fat stimulates gallbladder contraction and enterohepatic circulation, so a value drawn 2-4 hours after eating can differ meaningfully from an early-morning fasting sample without either sample being “wrong.”

Do not deliberately eat a fatty meal to make the test positive, and do not skip food if pregnancy nausea makes fasting unsafe. The goal is an interpretable clinical measurement, not a number engineered around a threshold; the ordering team may request a repeat under more standardized conditions if the result sits close to a decision boundary.

Laboratories also vary in pre-analytic instructions, which is why a photo of the complete report is more useful than a transcribed flag. Our blood-test PDF checking guide outlines details to verify before any automated interpretation.

Which liver tests should follow high bile acids?

High bile acids should usually be followed with bilirubin, ALT, AST, alkaline phosphatase, GGT, albumin, and often a full blood count and clotting assessment when liver dysfunction is suspected. A cholestatic pattern features ALP and GGT rising more than ALT and AST, but pregnancy makes ALP harder to interpret because placental ALP normally increases.

Comparison illustration of liver chemistry patterns in bile flow impairment and hepatocyte injury
Figure 7: Cholestatic and hepatocellular patterns direct different follow-up investigations.

ALT and AST can be normal in ICP, mildly raised, or occasionally substantially elevated; normal transaminases do not invalidate a raised bile-acid result. Conversely, elevated ALT with normal bile acids may reflect viral hepatitis, fatty liver disease, medication injury, or another hepatocellular process rather than ICP.

ALP is produced by placenta as well as liver, so an isolated high ALP in late pregnancy is not a reliable cholestasis marker. GGT is often normal or low in typical ICP; a conspicuously high GGT can prompt clinicians to consider an alternative biliary or medication-related explanation, especially outside pregnancy.

The cholestasis liver-test pattern is useful preparation for a follow-up visit. Kantesti’s neural network reads these markers as a pattern and highlights missing complementary tests, rather than asserting that one abnormal enzyme identifies a diagnosis.

What else causes high bile acids outside pregnancy?

High bile acids outside pregnancy can result from bile duct obstruction, primary biliary cholangitis, primary sclerosing cholangitis, viral hepatitis, drug-induced liver injury, advanced fatty liver disease, and some inherited transport disorders. The next test depends on the liver pattern, symptoms, medication exposure, and whether bilirubin is conjugated.

Medical molecular view of bile acids moving through hepatocyte transport proteins
Figure 8: Bile-acid transport proteins can be disrupted by liver disease or medicines.

A sudden rise with colicky upper abdominal pain, fever, and jaundice raises concern for obstruction or biliary infection and needs urgent clinical assessment, often with ultrasound. A gradual itch-plus-fatigue pattern in a middle-aged adult, particularly with high ALP and positive antimitochondrial antibodies, points clinicians toward autoimmune cholestatic disease instead.

Medication history is unusually high yield here. Antibiotics such as amoxicillin-clavulanate, anabolic agents, some antifungals, and certain herbal or bodybuilding products can produce a cholestatic pattern weeks after exposure; stopping a prescribed medicine without advice is not safe, but reporting every product is essential.

When I review this pattern, I often pair it with positive antimitochondrial antibody results only when the clinical context justifies that test. A high bile-acid number is a signal to investigate bile handling, not proof of one specific disease.

How intrahepatic cholestasis of pregnancy is managed

Intrahepatic cholestasis of pregnancy is managed by an obstetric team using symptom treatment, repeat blood testing, assessment of other pregnancy risks, and delivery timing based chiefly on peak bile acids and gestational age. Ursodeoxycholic acid may improve maternal itch and liver biochemistry, but it has not been shown to eliminate fetal risk.

Patient journey showing maternity clinician reviewing bile acid results on a tablet
Figure 9: Obstetric review combines laboratory trends, symptoms, gestational age, and fetal assessment.

Ursodeoxycholic acid is commonly prescribed at an initial dose around 10-15 mg/kg/day, often divided into 2 or 3 doses, with adjustment under specialist supervision. The PITCHES trial found no reduction in a composite adverse perinatal outcome with routine use, though some patients experience worthwhile itch relief; that distinction matters when expectations are set.

Antenatal testing can be reassuring but cannot reliably predict or prevent every stillbirth associated with severe ICP. SMFM recommends offering delivery at 36 0/7 to 39 0/7 weeks for bile acids below 100 micromol/L and at 36 0/7 weeks for levels of 100 micromol/L or higher, with individualized exceptions (Lee et al., 2021).

Do not use antihistamines, herbal teas, or topical products as a substitute for reporting new pregnancy itch. The pregnancy lab-safe supplement guide explains why “natural” does not automatically mean liver-safe.

When high bile acids need ultrasound or specialist review

High bile acids need imaging or specialist review when the liver pattern suggests obstruction, bilirubin rises, pain or fever is present, symptoms persist after pregnancy, or the clinical course is atypical for ICP. Ultrasound is commonly the first imaging test because it can assess gallstones, bile-duct dilation, and liver appearance without ionizing radiation.

Anatomical context illustration of liver, gallbladder and bile ducts for ultrasound assessment
Figure 10: Ultrasound evaluates the gallbladder and ducts when obstruction is clinically possible.

In straightforward ICP, abdominal ultrasound is not always necessary because the condition is functional cholestasis rather than a blocked duct. But a total bilirubin above 34 micromol/L (2 mg/dL), focal right-upper abdominal pain, fever, or a markedly raised GGT shifts the balance toward looking for another process.

Clinicians may calculate an R ratio using ALT divided by its upper limit of normal, then divided by ALP divided by its upper limit of normal. An R ratio above 5 is hepatocellular, below 2 is cholestatic, and 2-5 is mixed; it is a useful classification tool, not a diagnosis.

For chronic liver-risk context, a FIB-4 interpretation can be informative outside pregnancy, although it is not validated as a decision tool for ICP. Pregnancy itself alters platelets and liver chemistry, so specialist judgement comes first.

Urgent warning signs: do not wait for repeat testing

Seek urgent same-day medical care for itching with jaundice, fever, severe right-upper abdominal pain, persistent vomiting, confusion, easy bleeding, very dark urine, pale stool, or rapidly worsening illness. In pregnancy, reduced or changed fetal movements require immediate contact with maternity services regardless of a recent bile-acid value.

Clinical triage scene with hands reviewing liver warning signs beside urgent laboratory samples
Figure 11: Symptoms and pregnancy status determine urgency more reliably than a single lab flag.

A person with itching, temperature above 38.0 degrees C, jaundice, and upper abdominal pain may have biliary infection or acute liver disease; this is not a watch-and-wait scenario. Similarly, confusion, drowsiness, new bruising, or bleeding may indicate impaired liver function and warrants emergency assessment.

For pregnancy, do not wait until the next morning to report a genuine reduction in movement after the usual individual pattern has been established. Eat or drink something only if it helps you notice movement while arranging contact; it should never be used to delay a call to maternity triage.

Dark urine can reflect dehydration, medicines, bilirubin, or muscle pigment, so it needs context. Our dark urine urgent-care guide helps clarify the questions a clinician will ask, but it cannot assess fetal wellbeing.

What happens to bile acids after delivery?

Bile acids and liver tests from intrahepatic cholestasis of pregnancy usually improve after delivery and should be rechecked if symptoms or abnormal tests persist. Persistent itch, jaundice, or abnormal liver chemistry beyond 6 weeks postpartum deserves evaluation for another liver or biliary condition.

Microscopic liver tissue illustration showing recovery of bile canaliculi after pregnancy cholestasis
Figure 12: Postpartum follow-up confirms that cholestatic markers return toward the expected range.

Most patients notice itch easing within days of birth, often before every laboratory marker has normalized. A follow-up liver panel and bile acids at around 6 weeks is a sensible safety net in many care pathways, particularly after moderate or severe disease, although local maternity services differ in their exact schedule.

A previous ICP episode raises recurrence risk in a later pregnancy, commonly quoted as 45-90% depending on population and severity. That broad interval reflects genuine uncertainty: genetics, multiple pregnancy, assisted reproduction, and hormone exposure likely influence risk, but no single prediction test is definitive.

After recovery, keep a copy of the peak bile-acid value and date of diagnosis. It also helps to understand bilirubin patterns after pregnancy if a later result is flagged, because isolated bilirubin and cholestatic liver disease are different clinical puzzles.

How Kantesti interprets bile acids with liver results

Kantesti interprets a bile-acid result by checking units, the laboratory reference interval, pregnancy context, symptom flags, and accompanying liver markers rather than labelling a result in isolation. A result at or above 100 micromol/L in a reported pregnancy context should trigger immediate advice to contact the obstetric team, not a reassurance message.

AI-assisted clinical review of bile acid trend with liver biomarkers in a modern hospital setting
Figure 13: Trend-based interpretation links bile acids to the wider liver chemistry pattern.

Kantesti is an AI-powered blood test analysis tool used across more than 127 countries, so our system is designed to recognize that units, reference intervals, and maternity pathways vary by laboratory and region. It can organize the questions for the treating team, but it cannot diagnose ICP, determine delivery timing, or interpret fetal movements.

Dr. Thomas Klein, MD, and our clinical reviewers emphasize a small but vital safeguard: never upload a result without preserving the collection date, gestational week, fasting status if known, and complete laboratory page. Kantesti’s medical validation standards describe the clinical-oversight approach behind contextual lab interpretation.

If a report contains ALP, GGT, bilirubin, ALT, and AST but not bile acids, our system identifies that bile acids may be a missing test in pregnancy itch rather than inventing a value. The AI interpretation technology guide explains why source-document checks remain part of safe automated analysis.

Questions to ask after a high bile acids result

After a high bile acids result, ask whether the sample was fasting or non-fasting, what the peak value is, whether the laboratory interval fits the assay, and when testing will be repeated. In pregnancy, also ask who to call for changed movements and what delivery-timing plan applies to your specific peak level and gestational age.

Clinical process flow of bile acid result review, repeat testing, and obstetric follow-up
Figure 14: A structured question list reduces missed details during bile-acid follow-up discussions.

Bring a dated symptom timeline rather than relying on memory: onset of itch, palms or soles involved, visible rash, sleep loss, medications, supplements, urine colour, stool colour, and any pain. That list can distinguish a rising biochemical process from a persistent dermatologic one and makes repeat-test decisions much more precise.

Ask whether hepatitis screening, ultrasound, autoimmune markers, or medication changes are indicated by your liver pattern. There is no universal panel for every person with high bile acids; ordering every rare test at once creates false positives and can distract from the time-sensitive problem.

Kantesti is an AI biomarker interpretation platform built to help patients prepare for these conversations by preserving trends and explaining common patterns in plain language. Our Medical Advisory Board supports physician-led review principles: an app can organize evidence, but the clinician caring for you makes the diagnostic and treatment decisions.

Research evidence and clinical standards behind bile acid interpretation

As of September 15, 2026, the best-established risk threshold in intrahepatic cholestasis of pregnancy remains a peak total bile acid level of 100 micromol/L, based on individual participant data rather than itch severity alone. Evidence is less certain for lower values, where maternal symptoms and obstetric factors still guide individualized care.

Ovadia et al. pooled data from 5,269 women with ICP and showed that bile-acid concentration was more useful for stillbirth stratification than ALT, AST, or bilirubin alone (Ovadia et al., 2019). The evidence does not mean lower levels are “risk free”; it means the measurable excess stillbirth risk was concentrated most clearly at the highest peak range.

Kantesti’s research reporting follows a clinical-validation framework that separates extraction accuracy from medical interpretation and triage safety. Readers who want the organization’s broader methodology can review our clinical workflow examples and the cited validation records below; neither should be used to self-manage pregnancy complications.

For a human second look at a confusing report, Dr. Thomas Klein recommends bringing the original PDF and symptom timeline to the clinician rather than relying on copied numbers. That simple habit catches unit errors, especially when a laboratory reports bile acids in a format unfamiliar to the patient.

Frequently Asked Questions

What is a normal bile acids blood test result in pregnancy?

A non-fasting total bile acid result below 19 micromol/L does not meet the UK diagnostic threshold for intrahepatic cholestasis of pregnancy, but it does not fully exclude early disease when typical itching continues. The Royal College of Obstetricians and Gynaecologists classifies 19-39 micromol/L as mild ICP, 40-99 micromol/L as moderate ICP, and 100 micromol/L or higher as severe ICP. Laboratories and regions may use different methods or reference intervals, so the printed report and maternity team's protocol take priority. Persistent palm-and-sole itch without rash should be reported even after an initially normal result.

Can bile acids be high with normal liver enzymes?

Yes, bile acids can be elevated while ALT, AST, bilirubin, and GGT remain within their laboratory reference intervals, particularly early in intrahepatic cholestasis of pregnancy. A normal liver panel therefore does not replace a bile acids blood test when pregnancy itching is clinically suggestive. Conversely, high liver enzymes with normal bile acids can indicate another liver condition such as viral hepatitis, medication injury, or fatty liver disease. Clinicians interpret the complete liver pattern and symptoms together rather than using one test as a rule-out tool.

Should I fast before a bile acids blood test?

You should follow the ordering laboratory's instructions, but suspected pregnancy cholestasis should not be delayed simply because you have eaten. Current UK maternity guidance accepts non-fasting bile-acid testing, while food intake can still affect the numerical concentration through normal enterohepatic circulation. Record whether the sample was fasting and roughly when you last ate, especially if a result is near 19 or 40 micromol/L. Your maternity clinician may request a repeat under standardized conditions if the result and symptoms do not align.

How quickly should bile acids be repeated if I am still itching?

Persistent typical itching in pregnancy after a normal initial result commonly leads to repeat bile acids and liver tests in about 1 week, with an earlier review if symptoms worsen. The appropriate interval depends on gestational age, severity of itch, prior results, jaundice, and fetal-movement concerns. Reduced fetal movements require immediate maternity contact regardless of the planned repeat-test date or a previous result below 19 micromol/L. Do not wait for a scheduled blood draw if fever, severe abdominal pain, jaundice, or acute illness develops.

What bile acid level is dangerous in pregnancy?

A peak total bile acid concentration of 100 micromol/L or higher is the range most consistently linked to increased stillbirth risk and is classified as severe intrahepatic cholestasis of pregnancy. In the Ovadia et al. 2019 meta-analysis, stillbirth prevalence in singleton pregnancies was 3.44% at this level, compared with 0.13% below 40 micromol/L. Any value of 19 micromol/L or higher with pregnancy itching still needs maternity-led assessment and a plan for monitoring and timing of birth. Risk depends on the peak level, gestation, multiple pregnancy, coexisting conditions, and clinical course.

Do bile acids return to normal after delivery?

Bile acids and itch from intrahepatic cholestasis of pregnancy usually improve after delivery, often with symptom relief in the first several days. Many maternity pathways arrange liver chemistry and sometimes bile-acid follow-up at around 6 weeks postpartum, particularly after more marked elevation. Ongoing itch, jaundice, or abnormal results beyond 6 weeks should trigger evaluation for a non-pregnancy liver or biliary condition. A prior ICP diagnosis also raises recurrence risk in future pregnancies, often estimated between 45% and 90%.

Get AI-Powered Blood Test Analysis Today

Join over 2 million users worldwide who trust Kantesti for instant, accurate lab test analysis. Upload your blood test results and receive comprehensive interpretation of 15,000+ biomarkers in seconds.

📚 Referenced Research Publications

1

Klein, T., Mitchell, S., & Weber, H. (2026). Kantesti LTD. (2026). Clinical Validation Framework v2.0 (Medical Validation Page). Zenodo. https://doi.org/10.5281/zenodo.17993721. Kantesti AI Medical Research.

2

Klein, T., Mitchell, S., & Weber, H. (2026). Kantesti LTD. (2026). AI Blood Test Analyzer: 2.5M Tests Analyzed | Global Health Report 2026. Zenodo. https://doi.org/10.5281/zenodo.18175532. Kantesti AI Medical Research.

📖 External Medical References

3

Ovadia C et al. (2019). Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses. The Lancet.

4

Lee RH et al. (2021). Society for Maternal-Fetal Medicine Consult Series #53: Intrahepatic cholestasis of pregnancy. American Journal of Obstetrics and Gynecology.

5

Royal College of Obstetricians and Gynaecologists (2022). Intrahepatic cholestasis of pregnancy: Green-top Guideline No. 43. RCOG Green-top Guideline.

2M+Tests Analyzed
127+Countries
75+Languages

⚕️ Medical Disclaimer

E-E-A-T Trust Signals

Experience

Physician-led clinical review of lab interpretation workflows.

📋

Expertise

Laboratory medicine focus on how biomarkers behave in clinical context.

👤

Authoritativeness

Written by Dr. Thomas Klein with review by Dr. Sarah Mitchell and Prof. Dr. Hans Weber.

🛡️

Trustworthiness

Evidence-based interpretation with clear follow-up pathways to reduce alarm.

🏢 Kantesti LTD Registered in England & Wales · Company No. 17090423 London, United Kingdom · kantesti.net
blank
By Prof. Dr. Thomas Klein

Dr. Thomas Klein is a board-certified clinical hematologist serving as Chief Medical Officer at Kantesti AI. With over 15 years of experience in laboratory medicine and a strong interest in AI-supported interpretation of blood test results, he works to connect new technology with everyday clinical practice. His areas of interest include biomarker analysis, clinical decision support research and population-specific reference range optimization. As CMO, he contributes clinical input to the platform's internal benchmarking and provides clinical oversight for the medical quality of Kantesti's educational reports.

Leave a Reply

Your email address will not be published. Required fields are marked *